Patents contain some of the most valuable scientific information in antibody discovery. Long before a therapeutic reaches the clinic or appears in publications, critical details about sequences, variants, binding characteristics, and engineering approaches are often disclosed in patent filings.

For discovery scientists, computational biologists, and antibody engineers, patents represent an enormous source of competitive and scientific intelligence. The challenge is that extracting useful information from patents is often tedious, manual, and time-consuming.

Scientists regularly spend hours reviewing lengthy patent documents, locating sequence listings, comparing variants, and transferring data into spreadsheets for downstream analysis.

To make this process easier, Converge has developed a free online Patent Extractor tool that helps researchers quickly identify and organize antibody-related information from patent documents.

Why Discovery Teams Extract Antibody Intelligence from Patents

Patents are often the earliest public source of information about therapeutic antibody programs. They can reveal:

• Candidate molecules

• Sequence variants

• CDR information

• Engineering strategies

• Binding and affinity data

• Target-specific development approaches

For research and discovery teams, patent intelligence supports a wide range of activities:

• Lead optimization

• Target evaluation

• Competitive landscape assessment

• Dataset generation

• Sequence comparison

• Prior art review

Many organizations also use patent-derived information to enrich internal research workflows and support decision-making across discovery programs.

Because patents frequently contain information that is unavailable elsewhere, they have become an important resource for both experimental and computational teams.

How Is Antibody Data Extracted from Patents Today?

Despite their value, patents remain difficult to work with.

Most scientists still rely on highly manual workflows that involve:

• Downloading patent PDFs

• Searching through hundreds of pages

• Identifying relevant sequence listings

• Copying sequences into spreadsheets

• Reformatting tables

• Organizing extracted data for further analysis

This process becomes even more challenging when dealing with:

• Multiple sequence variants

• Large patent families

• Complex numbering systems

• Extensive experimental sections

• Inconsistent formatting

Many teams perform this work repeatedly across dozens or even hundreds of patents.

As a result, valuable scientific time is often spent on data collection rather than scientific interpretation.

This challenge has created growing interest in automated antibody sequence extraction workflows that can transform patents into structured, usable datasets.

Introducing the Converge Patent Extractor Tool

The Converge Patent Extractor is a free online tool designed to help researchers quickly extract antibody-related information from patent documents.

Rather than manually searching through lengthy filings, scientists submit a patent ID (e.g., US6217866) and receive structured outputs that are ready for downstream analysis.

The tool is built specifically for antibody-focused workflows and helps organize information that would otherwise require extensive manual review.

With the Patent Extractor, users can:

• Identify relevant antibody sequences with full functional data

• Extract CDR information

• Capture sequence variants

• Organize experimental data

• Structure patent-derived information for further research

The goal is simple:

Turn complex patent documents into usable scientific intelligence.

The tool is available free of charge and can be accessed here:

For teams involved in antibody patent analysis, this significantly reduces the effort required to move from raw patent documents to actionable data.

How to Use the Patent Extractor: Step by Step

Getting started requires only a few steps.

Step 1: Submit a Patent

Provide the patent ID you would like to analyze.

The system will begin processing the document automatically.

Step 2: Wait for Processing

The extractor reviews the patent and identifies relevant antibody-related content.

Depending on document complexity, processing may take up to a few hours.

Step 3: Review Results

Once complete, structured outputs become available for exploration. Users will receive an email to access the results.

Users can review extracted information and identify relevant sequences and supporting data.

Step 4: Export and Analyze

The extracted information can then be incorporated into downstream research workflows, comparative analyses, or internal datasets.

The entire process is designed to reduce manual effort while improving accessibility of patent-derived information.

What You Can Do with Extracted Antibody Sequences

Patent-derived antibody data becomes significantly more valuable once it has been organized into a structured format.

Researchers use extracted information for a variety of applications, including:

Lead Optimization

Discovery teams can compare variants, identify engineering strategies, and evaluate candidate molecules disclosed in patents.

Competitive Intelligence

Patent data helps researchers understand how other organizations are approaching a target, modality, or therapeutic area.

Sequence Analysis

Scientists can evaluate sequence relationships, identify similarities, and investigate diversification strategies across disclosed antibodies.

Dataset Generation

Computational biology and AI teams frequently require structured sequence datasets for model development and research workflows.

Internal Knowledge Management

Patent information can be incorporated into internal repositories, making scientific intelligence easier to access and share across teams.

Research Planning

Structured patent information helps support hypothesis generation and informs future discovery decisions.

Many organizations combine patent-derived information with internal datasets, literature findings, and public resources to create a more complete view of the antibody landscape.

In this context, patents serve as an important complement to an existing antibody sequence database or other scientific resources.

Similarly, teams conducting antibody patent search activities can use extracted information to accelerate evaluation and comparison workflows.

For organizations involved in antibody patent mining, automation helps scale analysis efforts while reducing manual review time.

Patent-derived information may also complement data sourced from a broader therapeutic antibody patent database, helping researchers build a more comprehensive understanding of the competitive landscape.

Why Automated Patent Extraction Matters

As antibody discovery programs become increasingly sophisticated, the volume of available patent information continues to grow.

Manual approaches that worked for reviewing a handful of patents often become unsustainable at larger scales.

Our automated patent extraction tool offers several advantages:

• Faster access to relevant information

• Reduced manual workload

• Improved consistency

• Better support for computational workflows

• Easier collaboration across teams

Most importantly, it allows scientists to spend more time interpreting data and less time collecting it.

Researchers should focus on scientific decisions—not repetitive data extraction tasks.

FAQs

Start Extracting Antibody Intelligence Today

Patent documents contain an extraordinary amount of scientific value, but manually collecting that information can slow down discovery efforts.

Converge’s Patent Extractor helps researchers move from unstructured patent documents to organized scientific data faster and with less effort.

If you're looking to extract antibody sequences from patents and accelerate patent-driven research workflows, try the Converge Patent Extractor today:

To learn more about Converge’s antibody solutions:

To talk with our experts: